Inozyme Pharma, Inc.
INZYDelisted Jul 1, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001693011
Inozyme Pharma, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 3, 2025; 87 institutions reported holding it in 13F filings for Q2 2025, worth $202.3M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Inozyme Pharma, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- −2 vs. Q1 2022
- Shares held
- 31.5M
- +14.1M (+81.3%) vs. Q1 2022
- Total value
- $149.4M
- +$78.2M (+109.8%) vs. Q1 2022
- New holders
- 13
- 18 more added
- Sold out
- 15
- 14 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INZY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 87 | $202.3M |
| Q1 2025 | 97 | $42.5M |
| Q4 2024 | 105 | $145.1M |
| Q3 2024 | 89 | $285.5M |
| Q2 2024 | 90 | $240.1M |
| Q1 2024 | 89 | $382.0M |
| Q4 2023 | 80 | $213.3M |
| Q3 2023 | 77 | $204.6M |
| Q2 2023 | 74 | $190.3M |
| Q1 2023 | 50 | $183.4M |
| Q4 2022 | 37 | $30.4M |
| Q3 2022 | 39 | $82.7M |
| Q2 2022 | 47 | $149.4M |
| Q1 2022 | 50 | $71.2M |
| Q4 2021 | 51 | $118.2M |
| Q3 2021 | 52 | $202.7M |
| Q2 2021 | 50 | $337.1M |
| Q1 2021 | 55 | $379.4M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Inozyme Pharma, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sofinnova Investments, Inc. | 3,655,308 | $17.4M | 1.55% | +1,627,000+80.2% | Added |
| Deep Track Capital, LP | 3,250,000 | $15.5M | 1.07% | +3,250,000 | New |
| VR Adviser, LLC | 2,709,987 | $12.9M | 2.55% | +2,709,987 | New |
| Deerfield Management Company, L.P. (Series C) | 2,696,372 | $12.9M | 0.27% | +351,586+15.0% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 2,661,154 | $12.7M | 6.39% | +1,070,000+67.2% | Added |
| Rock Springs Capital Management LP | 2,640,056 | $12.6M | 0.37% | +1,446,861+121.3% | Added |
| Adage Capital Partners GP, L.L.C. | 2,546,672 | $12.1M | 0.03% | +800,000+45.8% | Added |
| NEA Management Company, LLC | 2,444,379 | $10.5M | 0.54% | 00.0% | Unchanged |
| CHI Advisors LLC | 2,033,802 | $9.70M | 3.71% | +1,141,745+128.0% | Added |
| Vanguard Group Inc | 1,354,216 | $6.46M | 0.00% | +864,603+176.6% | Added |
| Sphera Funds Management Ltd. | 1,165,600 | $5.56M | 1.06% | +1,165,600 | New |
| Janus Henderson Group PLC | 929,956 | $4.46M | 0.00% | +409,193+78.6% | Added |
| MPM Oncology Impact Management LP | 664,980 | $3.17M | 0.88% | +370,000+125.4% | Added |
| FMR LLC | 609,819 | $2.91M | 0.00% | +2250.0% | Added |
| BlackRock Inc. | 430,520 | $2.05M | 0.00% | −447,880−51.0% | Reduced |
| Laurion Capital Management LP | 271,800 | $1.30M | 0.05% | +261,800+2,618.0% | Added |
| Geode Capital Management, LLC | 216,925 | $1.03M | 0.00% | +30,918+16.6% | Added |
| Millennium Management LLC | 173,092 | $826.0K | 0.00% | +173,092 | New |
| UBS Oconnor LLC | 171,347 | $817.0K | 0.01% | +171,347 | New |
| Citadel Advisors LLC | 120,827 | $577.0K | 0.00% | +22,530+22.9% | Added |
| Renaissance Technologies LLC | 118,300 | $564.0K | 0.00% | +106,400+894.1% | Added |
| Baker Bros. Advisors LP | 106,999 | $510.0K | 0.00% | 00.0% | Unchanged |
| Walleye Capital LLC | 101,442 | $484.0K | 0.01% | +101,442 | New |
| Bridgeway Capital Management, LLC | 87,400 | $417.0K | 0.01% | +30,000+52.3% | Added |
| Overbrook Management Corp | 69,326 | $331.0K | 0.10% | +52,600+314.5% | Added |
| State of Wisconsin Investment Board | 68,900 | $329.0K | 0.00% | +68,900 | New |
| State Street Corp | 49,055 | $234.0K | 0.00% | −139,950−74.0% | Reduced |
| Northern Trust Corp | 46,990 | $224.0K | 0.00% | −66,833−58.7% | Reduced |
| Morgan Stanley | 41,174 | $197.0K | 0.00% | +25,237+158.4% | Added |
| Ergoteles LLC | 25,649 | $122.0K | 0.00% | +25,649 | New |
| Bank of New York Mellon Corp | 21,898 | $105.0K | 0.00% | −18,115−45.3% | Reduced |
| Charles Schwab Investment Management Inc | 16,549 | $79.0K | 0.00% | −13,948−45.7% | Reduced |
| Dimensional Fund Advisors LP | 13,087 | $63.0K | 0.00% | +13,087 | New |
| Goldman Sachs Group Inc | 12,505 | $60.0K | 0.00% | −750−5.7% | Reduced |
| Virtu Financial LLC | 11,179 | $53.0K | 0.00% | +11,179 | New |
| Barclays PLC | 6,403 | $31.0K | 0.00% | −2,337−26.7% | Reduced |
| Nisa Investment Advisors, LLC | 4,800 | $23.0K | 0.00% | +4,800 | New |
| Royal Bank of Canada | 469 | $2.00K | 0.00% | −415−46.9% | Reduced |
| Citigroup Inc | 143 | $1.00K | 0.00% | −12,374−98.9% | Reduced |
| UBS Group AG | 115 | $1.00K | 0.00% | −6,198−98.2% | Reduced |
| New York State Common Retirement Fund | 117 | $1.00K | 0.00% | −3,717−96.9% | Reduced |
| Wells Fargo & Company | 177 | $1.00K | 0.00% | −2,778−94.0% | Reduced |
| Crewe Advisors LLC | 163 | $1.00K | 0.00% | +163 | New |
| JPMorgan Chase & Co | 60 | $0 | 0.00% | −310,873−100.0% | Reduced |
| Bank of America Corp | 7 | $0 | 0.00% | −6,640−99.9% | Reduced |
| Ellevest, Inc. | 76 | $0 | 0.00% | +38+100.0% | Added |
| Credit Suisse AG | 8 | $0 | 0.00% | +8 | New |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −1,013,216−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −43,574−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −12,890−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −11,350−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −10,916−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −10,273−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −7,810−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −7,144−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −5,996−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,430−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1,732−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,147−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −692−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −451−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |